Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

[1]  D. Guertin,et al.  The Pharmacology of mTOR Inhibition , 2009, Science Signaling.

[2]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[3]  Robbie Loewith,et al.  Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.

[4]  Sang Gyun Kim,et al.  Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation , 2008, Proceedings of the National Academy of Sciences.

[5]  S. Germain,et al.  Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. , 2008, The Journal of clinical investigation.

[6]  Davide Ruggero,et al.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.

[7]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[8]  David E. Housman,et al.  mTORC1 promotes survival through translational control of Mcl-1 , 2008, Proceedings of the National Academy of Sciences.

[9]  S. Jhanwar,et al.  A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. , 2008, Cancer research.

[10]  M. Birnbaum,et al.  Akt1 and Akt2 are required for αβ thymocyte survival and differentiation , 2007, Proceedings of the National Academy of Sciences.

[11]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[12]  T. Ludwig,et al.  Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition1 , 2007, The Journal of Immunology.

[13]  M. Birnbaum,et al.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[14]  N. Hay,et al.  Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. , 2006, Cancer cell.

[15]  O. Meyuhas,et al.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.

[16]  Wei Xu,et al.  Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita , 2006, Science.

[17]  M. Ciofani,et al.  A survival guide to early T cell development , 2006, Immunologic research.

[18]  Nahum Sonenberg,et al.  The Akt of translational control , 2005, Oncogene.

[19]  Yuval Dor,et al.  Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. , 2005, Genes & development.

[20]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[21]  N. Sonenberg,et al.  Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.

[22]  P. Pandolfi,et al.  The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.

[23]  S. Lowe,et al.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.

[24]  J. Zúñiga-Pflücker.  T-cell development made simple , 2004, Nature Reviews Immunology.

[25]  S. Korsmeyer,et al.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 , 2003, Nature.

[26]  N. Socci,et al.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.

[27]  Thomas M. Schmitt,et al.  Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. , 2002, Immunity.

[28]  Hua Tang,et al.  Transduction of Growth or Mitogenic Signals into Translational Activation of TOP mRNAs Is Fully Reliant on the Phosphatidylinositol 3-Kinase-Mediated Pathway but Requires neither S6K1 nor rpS6 Phosphorylation , 2002, Molecular and Cellular Biology.

[29]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[30]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[31]  P. Tsichlis,et al.  Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Hua Tang,et al.  Amino Acid-Induced Translation of TOP mRNAs Is Fully Dependent on Phosphatidylinositol 3-Kinase-Mediated Signaling, Is Partially Inhibited by Rapamycin, and Is Independent of S6K1 and rpS6 Phosphorylation , 2001, Molecular and Cellular Biology.

[33]  P. Vogt,et al.  Oncogenic transformation induced by membrane-targeted Akt2 and Akt3 , 2001, Oncogene.

[34]  C Benoist,et al.  How much TCR does a T cell need? , 2001, Immunity.

[35]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[36]  C. Benoist,et al.  Role of the forkhead transcription family member, FKHR, in thymocyte differentiation , 2000, European journal of immunology.

[37]  T. Haystead,et al.  Sites That Govern Translational Repression Phosphorylation of Phas-i in Five (s/t)p Multiple Mechanisms Control , 2022 .

[38]  D. Pennington,et al.  Co‐ordination of the expression of the protein tyrosine kinase p56lck with the pre‐T cell receptor during thymocyte development , 2000, European journal of immunology.

[39]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[40]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[41]  A. Gingras,et al.  4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.

[42]  A. Lambertsson.  The minute genes in Drosophila and their molecular functions. , 1998, Advances in genetics.

[43]  A. Gingras,et al.  The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k , 1997, Molecular and cellular biology.

[44]  N. Sonenberg,et al.  eIF4G Dramatically Enhances the Binding of eIF4E to the mRNA 5′-Cap Structure* , 1997, The Journal of Biological Chemistry.

[45]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[46]  Li Wu,et al.  Early T lymphocyte progenitors. , 1996, Annual review of immunology.

[47]  M. Siegmann,et al.  Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Staal.  Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Schultz,et al.  The Minute Reaction in the Development of DROSOPHILA MELANOGASTER. , 1929, Genetics.

[50]  T. Glaser,et al.  Summary Ribosomal protein L 24 defect in Belly spot and tail ( Bst ) , a mouse Minute , 2004 .